Krystal Biotech (KRYS)
(Delayed Data from NSDQ)
$176.39 USD
+3.86 (2.24%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $174.39 -2.00 (-1.13%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/04/2024
Time: BMO |
9/2024 | $0.84 | -3.28% |
Earnings Summary
For their last quarter, Krystal Biotech (KRYS) reported earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.50 per share. This reflects a positive earnings surprise of 72.00%. Look out for KRYS's next earnings release on November 04, 2024. For the next earning release, we expect the company to report earnings of $0.84 per share, reflecting a year-over-year increase of 225.37%.
Earnings History
Price & Consensus
Zacks News for KRYS
Will Apellis Pharmaceuticals, Inc. (APLS) Report Negative Earnings Next Week? What You Should Know
KRYS: What are Zacks experts saying now?
Zacks Private Portfolio Services